Mutant LRRK2 (R1441C) fibroblast lines and sporadic PD patient lines displayed less non-phosphorylated LRRK2 protein levels at baseline conditions (p < 0.05), in comparison to healthy subject controls (Fig. 1c). This evidence concerns the gene LRRK2 and Parkinson disease.